Contacto

Human Hyaluronidase 1 (HYAL1) CLIA Kit

737,50 (96 tests)

Human Hyaluronidase 1 (HYAL1) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.

Proveedor

Abbexa

Reference

abx190156

Tested Applications

CLIA

Reactivity

Human

Status

RUO

Si quieres saber los precios con descuentos por volumen o bien más características del producto, contáctanos!

Características de producto

tested_applications
CLIA
reactivity
Human
category
CLIA Kits
Immunogen / Target
Hyaluronidase 1 (HYAL1)
size_1
96 tests
size_2
5 × 96 tests
size_3
10 × 96 tests
storage
Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
uniprot_id
Q12794
gene_id
3373
omim
607071
test_range
0.69 ng/ml - 500 ng/ml
sensitivity
< 0.28 ng/ml
detection_method
Chemiluminescent
assay_type
Sandwich
assay_data
Quantitative
availability
Shipped within 5-7 working days.
dry_ice
No
note
This product is for research use only.

The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.

Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.
background
Hyaluronidase 1 (HYAL1) is an enzyme that hydrolyses 1,4 linkages between N-acetylglucosamine (GlcNAc) and glucuronic acid (GlcA) residues in hyaluronan, a glycosaminoglycan found in extracellular matrix. HYAL1 is expressed in the lysosomes of various tissues and is also secreted in plasma. The catalytic activity of HYAL1 is carried out by an aspartate and a glutamate residue in close proximity to each other, but also requires a distant tyrosine and asparagine residue to ensure correct binding to hyaluronan. Overexpression of HYAL1 occurs in some metastatic cancers, while mutations in the gene that reduce its catalytic activity can cause mucopolysaccharidosis IX, resulting in short stature and high serum hyaluronic acid concentrations. Target